155 related articles for article (PubMed ID: 30058675)
1. MiR-129 is involved in the occurrence of uterine fibroid through inhibiting TET1.
Lu JL; Zhao L; Han SC; Bi JL; Liu HX; Yue C; Lin L
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4419-4426. PubMed ID: 30058675
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA 21a-5p overexpression impacts mediators of extracellular matrix formation in uterine leiomyoma.
Cardozo ER; Foster R; Karmon AE; Lee AE; Gatune LW; Rueda BR; Styer AK
Reprod Biol Endocrinol; 2018 May; 16(1):46. PubMed ID: 29747655
[TBL] [Abstract][Full Text] [Related]
3. Regulation of Cell Cycle Regulatory Proteins by MicroRNAs in Uterine Leiomyoma.
Chuang TD; Khorram O
Reprod Sci; 2019 Feb; 26(2):250-258. PubMed ID: 29642801
[TBL] [Abstract][Full Text] [Related]
4. Systematic analysis of gene expression pattern in has-miR-197 over-expressed human uterine leiomyoma cells.
Ling J; Wu X; Fu Z; Tan J; Xu Q
Biomed Pharmacother; 2015 Oct; 75():226-33. PubMed ID: 26311392
[TBL] [Abstract][Full Text] [Related]
5. From 2646 to 15: differentially regulated microRNAs between progenitors from normal myometrium and leiomyoma.
Lazzarini R; Caffarini M; Delli Carpini G; Ciavattini A; Di Primio R; Orciani M
Am J Obstet Gynecol; 2020 Jun; 222(6):596.e1-596.e9. PubMed ID: 31874141
[TBL] [Abstract][Full Text] [Related]
6. A Role for Progesterone-Regulated sFRP4 Expression in Uterine Leiomyomas.
Delaney MA; Wan YW; Kim GE; Creighton CJ; Taylor MG; Masand R; Park A; Valdes C; Gibbons W; Liu Z; Anderson ML
J Clin Endocrinol Metab; 2017 Sep; 102(9):3316-3326. PubMed ID: 28637297
[TBL] [Abstract][Full Text] [Related]
7. Lnc-AL445665.1-4 may be involved in the development of multiple uterine leiomyoma through interacting with miR-146b-5p.
Yang E; Xue L; Li Z; Yi T
BMC Cancer; 2019 Jul; 19(1):709. PubMed ID: 31319799
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of miR-29b is essential for pathogenesis of uterine leiomyoma.
Qiang W; Liu Z; Serna VA; Druschitz SA; Liu Y; Espona-Fiedler M; Wei JJ; Kurita T
Endocrinology; 2014 Mar; 155(3):663-9. PubMed ID: 24424054
[TBL] [Abstract][Full Text] [Related]
9. Effects of miRNA-197 overexpression on proliferation, apoptosis and migration in levonorgestrel treated uterine leiomyoma cells.
Wu X; Ling J; Fu Z; Ji C; Wu J; Xu Q
Biomed Pharmacother; 2015 Apr; 71():1-6. PubMed ID: 25960207
[TBL] [Abstract][Full Text] [Related]
10. MiR-365a-3p suppresses proliferation and invasion of Hep-2 cells through targeting ten-eleven translocation 1 (TET1).
Li J; Shen N; Bai GP; Huang XS
Neoplasma; 2018 Sep; 65(5):730-735. PubMed ID: 30249104
[TBL] [Abstract][Full Text] [Related]
11. miR-27a-3p promotes the malignant phenotypes of osteosarcoma by targeting ten-eleven translocation 1.
Liu J; Li M; Liu X; Liu F; Zhu J
Int J Oncol; 2018 Apr; 52(4):1295-1304. PubMed ID: 29484426
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms underlying aberrant expression of miR-29c in uterine leiomyoma.
Chuang TD; Khorram O
Fertil Steril; 2016 Jan; 105(1):236-45.e1. PubMed ID: 26453978
[TBL] [Abstract][Full Text] [Related]
13. MiR-520b suppresses proliferation of hepatoma cells through targeting ten-eleven translocation 1 (TET1) mRNA.
Zhang W; Lu Z; Gao Y; Ye L; Song T; Zhang X
Biochem Biophys Res Commun; 2015 May; 460(3):793-8. PubMed ID: 25824049
[TBL] [Abstract][Full Text] [Related]
14. Functional role of the long noncoding RNA X-inactive specific transcript in leiomyoma pathogenesis.
Chuang TD; Rehan A; Khorram O
Fertil Steril; 2021 Jan; 115(1):238-247. PubMed ID: 33070965
[TBL] [Abstract][Full Text] [Related]
15. Cross-talk between miR-29c and transforming growth factor-β3 is mediated by an epigenetic mechanism in leiomyoma.
Chuang TD; Khorram O
Fertil Steril; 2019 Dec; 112(6):1180-1189. PubMed ID: 31843095
[TBL] [Abstract][Full Text] [Related]
16. Locostatin, a disrupter of Raf kinase inhibitor protein, inhibits extracellular matrix production, proliferation, and migration in human uterine leiomyoma and myometrial cells.
Janjusevic M; Greco S; Islam MS; Castellucci C; Ciavattini A; Toti P; Petraglia F; Ciarmela P
Fertil Steril; 2016 Nov; 106(6):1530-1538.e1. PubMed ID: 27565262
[TBL] [Abstract][Full Text] [Related]
17. FKBP51 Contributes to Uterine Leiomyoma Pathogenesis by Inducing Cell Proliferation and Extracellular Matrix Deposition.
New EP; Semerci N; Ozmen A; Guo X; Jonnalagadda VA; Kim JW; Anderson ML; Guzeloglu-Kayisli O; Imudia AN; Lockwood CJ; Kayisli UA
Reprod Sci; 2022 Jun; 29(6):1939-1949. PubMed ID: 35426036
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of uterine fibroids and its implication for underlying mechanisms of pathogenesis.
Hoffman PJ; Milliken DB; Gregg LC; Davis RR; Gregg JP
Fertil Steril; 2004 Sep; 82(3):639-49. PubMed ID: 15374708
[TBL] [Abstract][Full Text] [Related]
19. PLIN2 Functions As a Novel Link Between Progesterone Signaling and Metabolism in Uterine Leiomyoma Cells.
Okeigwe I; Bulun S; Liu S; Rademaker AW; Coon JS; Kujawa S; Robins J; Yin P
J Clin Endocrinol Metab; 2019 Dec; 104(12):6256-6264. PubMed ID: 31504629
[TBL] [Abstract][Full Text] [Related]
20. Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics.
Islam MS; Ciavattini A; Petraglia F; Castellucci M; Ciarmela P
Hum Reprod Update; 2018 Jan; 24(1):59-85. PubMed ID: 29186429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
